Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema

Inclusion Criteria: * Male or non-pregnant female at least 18 years of age at the time of consent * One or both eyes having CME associated with non-infectious uveitis * Subject has the ability to understand and sign the Informed Consent Form * Subject is willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures Exclusion Criteria: * Allergy to triamcinolone acetonide * History of any type of non-infectious uveitis without macular edema * Vitreous hemorrhage * Uveitis with infectious etiology * CME due to non-uveitis causes * Previous viral retinitis or uveitis * Toxoplasmosis scar in study eye or scar related to viral retinitis * Media opacity interfering with optical coherence tomography (OCT) or evaluation of the retina and vitreous * Patient may not have had prior treatment for CME within the past 3 months including anti-VEGF (vascular endothelial growth factor), periocular or intravitreal steroid * Pregnant or nursing women; females of childbearing potential who are unwilling or unable to use an acceptable method of contraception * Subjects unwilling to comply with the study protocol or who are likely to be lost to follow-up within 6 months